Sandhya Subramaniam is a seasoned professional in the ophthalmic industry, currently serving as a Consultant in Clinical Science at Independent Consulting. With over 15 years of experience, Sandhya has honed her expertise in clinical development and medical affairs, particularly within the realms of ophthalmology and...
Sandhya Subramaniam is a seasoned professional in the ophthalmic industry, currently serving as a Consultant in Clinical Science at Independent Consulting. With over 15 years of experience, Sandhya has honed her expertise in clinical development and medical affairs, particularly within the realms of ophthalmology and optometry. Her advanced degree in Vision Science complements her extensive background, enabling her to navigate complex regulatory landscapes and contribute to innovative solutions in medical diagnostics.
At Regulatory Pathways Group Inc. (RPGI), Sandhya plays a pivotal role in guiding clients through the intricacies of clinical study design and regulatory submissions. Her deep understanding of FDA regulations and Investigational New Drug (IND) applications positions her as a key asset in the development of new ophthalmic therapies. Sandhya's involvement in key projects includes the design and execution of clinical trials aimed at evaluating novel treatments for retinal diseases and glaucoma, where her insights into clinical research methodologies have proven invaluable.
Her proficiency in medical affairs allows her to bridge the gap between clinical development and commercial strategy, ensuring that scientific data translates effectively into actionable insights for stakeholders. Sandhya's commitment to advancing the field of ophthalmology is evident in her collaborative approach, working closely with cross-functional teams to drive innovation and improve patient outcomes. As a thought leader in her field, she continues to contribute to the advancement of vision science, making a significant impact on the future of ophthalmic care.
